Yumanity Therapeutics Inc (YMTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | YMTX | AZN | AMGN | GILD | BMY |
| Company | Yumanity Therapeutics Inc | Astrazeneca Plc | Amgen Inc | Gilead Sciences Inc | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NYSE |
| Open | 1.6300 | 194.85 | 350.73 | 137.18 | 60.20 |
| High | 1.8900 | 197.27 | 355.49 | 140.35 | 61.13 |
| Low | 1.4000 | 193.55 | 347.11 | 137.17 | 59.92 |
| Latest | 1.8900 | 197.22 | 351.85 | 139.37 | 60.65 |
| Change | +0.1500 | +3.34 | +2.85 | +3.03 | +0.92 |
| % Change | +8.62% | +1.72% | +0.82% | +2.22% | +1.54% |
| Volume | 697,400 | 2,759,700 | 3,747,100 | 7,878,900 | 12,797,200 |
| 20-Day Average Volume | 312,450 | 1,907,010 | 2,699,920 | 6,331,705 | 13,891,771 |
| Previous Close | 1.7400 | 193.88 | 349.00 | 136.34 | 59.73 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 1.8773 | 191.15 | 360.60 | 141.92 | 59.41 |
| 20-Day Raw Stochastic | 59.76% | 70.96% | 19.61% | 35.38% | 68.46% |
| 20-Day Relative Strength | 52.61 | 54.89 | 45.33 | 47.31 | 56.56 |
| Weighted Alpha | -37.50 | +43.73 | +21.66 | +31.03 | +20.50 |
| Today's Opinion | 96% Buy | 72% Buy | 40% Buy | 40% Buy | 96% Buy |
| Previous Opinion | 64% Buy | 72% Buy | 40% Buy | 40% Buy | 88% Buy |
| Last Month's Opinion | 88% Buy | 100% Buy | 100% Buy | 100% Buy | 100% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -5.03% since 12/09/22 | +6.16% since 03/24/26 | +0.98% since 03/24/26 | +0.91% since 03/24/26 | +5.68% since 03/24/26 |
| Low | 1.4000 on 12/16/22 | 182.79 on 03/26/26 | 347.11 on 03/31/26 | 133.89 on 03/30/26 | 57.79 on 03/25/26 |
| High | 2.0900 on 12/13/22 | 197.27 on 03/31/26 | 358.00 on 03/25/26 | 140.41 on 03/25/26 | 61.13 on 03/31/26 |
| 1-Month | |||||
| %Chg | +3.95% since 11/16/22 | -5.39% since 02/27/26 | -9.35% since 02/27/26 | -6.43% since 02/27/26 | -2.76% since 02/27/26 |
| Low | 1.4000 on 12/16/22 | 182.39 on 03/24/26 | 344.95 on 03/20/26 | 133.89 on 03/30/26 | 56.45 on 03/24/26 |
| High | 2.2200 on 12/08/22 | 206.30 on 03/02/26 | 391.29 on 03/02/26 | 150.77 on 03/02/26 | 62.89 on 03/02/26 |
| 3-Month | |||||
| %Chg | +13.86% since 09/16/22 | +6.15% since 12/26/25 | +5.68% since 12/26/25 | +11.76% since 12/26/25 | +11.00% since 12/26/25 |
| Low | 1.4000 on 12/16/22 | 178.08 on 01/21/26 | 318.21 on 01/05/26 | 116.88 on 01/05/26 | 52.06 on 01/05/26 |
| High | 2.2200 on 12/08/22 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| 6-Month | |||||
| %Chg | +20.38% since 06/16/22 | +33.69% since 09/26/25 | +28.89% since 09/26/25 | +24.33% since 09/26/25 | +37.47% since 09/26/25 |
| Low | 1.4000 on 12/16/22 | 147.37 on 09/29/25 | 270.67 on 09/29/25 | 108.46 on 10/02/25 | 42.52 on 10/29/25 |
| High | 2.2200 on 12/08/22 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 20,518 | 300,690,048 | 188,134,720 | 169,228,192 | 121,952,832 |
| Shares Outstanding, K | 10,856 | 1,550,908 | 539,068 | 1,241,222 | 2,041,735 |
| Annual Sales | 8,040,000 | 58,739,000,000 | 36,751,000,000 | 29,443,000,000 | 48,194,000,000 |
| Annual Net Income | -39,500,000 | 10,225,000,000 | 7,711,000,000 | 8,510,000,000 | 7,054,000,000 |
| Last Quarter Sales | 1,400,000 | 15,503,000,000 | 9,866,000,000 | 7,925,000,000 | 12,502,000,000 |
| Last Quarter Net Income | -3,360,000 | 2,321,000,000 | 1,333,000,000 | 2,183,000,000 | 1,086,000,000 |
| 60-Month Beta | 0.32 | 0.32 | 0.45 | 0.36 | 0.26 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.31 on 11/14/22 | 2.12 on 02/10/26 | 5.29 on 02/03/26 | 1.86 on 02/10/26 | 1.26 on 02/05/26 |
| Latest Earnings Date | 03/23/23 | 05/05/26 | 05/07/26 | 04/23/26 | 04/30/26 |
| Most Recent Dividend | N/A | 2.170 on 02/20/26 | 2.520 on 02/13/26 | 0.820 on 03/13/26 | 0.630 on 01/02/26 |
| Next Ex-Dividends Date | N/A | 02/20/26 | 05/15/26 | 03/13/26 | 04/02/26 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 20.57 | 15.96 | 16.47 | 9.52 |